CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-08-20 | SHALLCROSS STEVEN A Chief Financial Officer | Purchase | +52,000 | $0.39 | $20K | 52,000 |
| 2014-04-08 | Field Edward L. CHIEF OPERATING OFFICER | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +300,000 | 834,000 | ||
| 2014-04-08 | SHALLCROSS STEVEN A SEE REMARKS | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +300,000 | 900,000 | ||
| 2014-04-08 | ROSENDALE MARTIN P CHIEF EXECUTIVE OFFICER | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +300,000 | 1,330,223 | ||
| 2014-04-08 | ROSENDALE MARTIN P CHIEF EXECUTIVE OFFICER | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +2,624,800 | 3,655,023 | ||
| 2014-04-08 | Field Edward L. CHIEF OPERATING OFFICER | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +1,285,900 | 1,819,900 | ||
| 2014-04-08 | SHALLCROSS STEVEN A SEE REMARKS | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +1,219,900 | 1,819,900 | ||
| 2014-01-28 | DEL GUERCIO JOSEPH Director | Grant or award · Options to purchase shares of Common Stock | +30,000 | 446,364 | ||
| 2014-01-28 | McLoughlin Mark T Director | Grant or award · Options to purchase shares of Common Stock | +30,000 | 420,000 | ||
| 2014-01-28 | Kent Richard S Director | Grant or award · Option to purchase shares of Common Stock | +30,000 | 30,000 | ||
| 2014-01-28 | WINZER C ERIC Director | Grant or award · Options to purchase shares of Common Stock | +40,000 | 240,000 | ||
| 2014-01-28 | KEITH STEPHEN Director | Grant or award · Options to purchase shares of Common Stock | +40,000 | 240,000 | ||
| 2014-01-28 | HOHNKE LYLE A Director | Grant or award · Options to purchase shares of Common Stock | +40,000 | 575,000 | ||
| 2013-06-13 | Aldagen Holdings, LLC 10% owner | Other disposition | −105,300 | 11,936,265 | ||
| 2013-05-21 | JORDEN DAVID EMERSON Director | Purchase | +55,000 | $0.50 | $28K | 6,905,000 |
| 2013-05-17 | JORDEN DAVID EMERSON Director | Purchase | +25,000 | $0.50 | $13K | 6,850,000 |
| 2013-04-19 | JORDEN DAVID EMERSON Director | Purchase | +15,000 | $0.50 | $8K | 6,875,000 |
| 2013-04-18 | JORDEN DAVID EMERSON Director | Purchase | +20,000 | $0.51 | $10K | 6,860,000 |
| 2013-04-17 | JORDEN DAVID EMERSON Director | Purchase | +15,000 | $0.51 | $8K | 6,840,000 |
| 2013-04-09 | JORDEN DAVID EMERSON Director | Purchase | +31,515 | $0.52 | $16K | 6,825,000 |
Page 10 of 17 · 326 trades